Evidence map›Paper›PMID 41216335›Full record

ArticleJournal of inflammation research2025

ICAM1-Mediated Endothelial Cells and Macrophage Interactions in Modulating GBM Malignant Transformation.

Junlin Li, Tingyu Liang, Bo Liang, Xiaoman Kang, Wenbo Wu, Hai Wang, Huiyu Yang, Yu Wang, Wenbin Ma

Abstract read
In one paragraph

Article in Journal of inflammation research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Junlin Li *Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Tingyu Liang *Department of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Bo Liang *Department of Neurosurgery, Beijing Ditan Hospital, Capital Medical University, Beijing, People's Republic of China.
Xiaoman KangDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Wenbo WuDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Hai WangDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Huiyu YangDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Yu WangDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.
Wenbin MaDepartment of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People's Republic of China.ORCID 0000-0003-4800-7992

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Glioblastoma (GBM) recurs frequently as the most common primary malignant brain tumor. Microvascular proliferation is a hallmark of GBM. Endothelial cells contribute to the tumor microenvironment (TME) in primary GBM and promote malignancy. However, their role in recurrent GBM (rGBM) remains unclear. Methods: An analysis was made of single-cell RNA data from GSE182109. Endothelial cells were isolated. Subclusters underwent differential expression and pseudotime trajectory analysis for the identification of signature genes. TCGA data confirmed the expression patterns and prognostic significance of signature genes. Immunofluorescence was performed on matched primary-recurrent GBM samples. Signature genes were knocked down in human umbilical vein endothelial cells (HUVECs). Co-culture experiments with THP-1 and U87 cells explored crosstalk mechanisms and their potential upstream and downstream pathways. Results: Two endothelial cell clusters were identified in single-cell analysis. Cluster 1 showed an elevation in rGBM and was associated with a poorer prognosis. Pseudotime analysis identified intercellular adhesion molecule-1 (ICAM1) as a signature gene. ICAM1 was up-regulated in rGBM, which was likely due to hypoxia. The knockdown of ICAM1 in endothelial cells reduced the adhesion of bone marrow-derived macrophages (BMDMs). Meanwhile, adrenomedullin (ADM) expression was decreased by lowering CCL2. Co-culture experiments demonstrated that macrophage-secreted ADM facilitated angiogenesis and the proliferation and migration of tumor cells. Conclusion: This study suggests that hypoxia induces endothelial cells to upregulate the expression of ICAM1 during GBM recurrence and facilitates the recruitment of BMDMs. Concurrently, endothelial-derived CCL2 induces the expression of ADM in BMDMs. This macrophage-derived ADM, in turn, accelerates angiogenesis in endothelial cells while enhancing the proliferation and migration of tumor cells. These results elucidate a feedforward loop in the endothelial-BMDM-tumor cell axis, and provide mechanistic insights into the TME of rGBM.

Indexed as

adrenomedullinendothelial cellsglioblastomaintercellular adhesion molecule 1

Identifiers

PMID41216335
PMCPMC12596846

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.